Clin Exp Otorhinolaryngol.  2020 Nov;13(4):315-317. 10.21053/ceo.2020.01606.

Genetic Information and Precision Medicine in Hearing Loss

• Oh DY
• Choi BY

• KMID: 2508505
• DOI: http://doi.org/10.21053/ceo.2020.01606

Reference

1. Morton CC, Nance WE. Newborn hearing screening: a silent revolution. N Engl J Med. 2006; May. 354(20):2151–64.

2. Smith RJ, Bale JF Jr, White KR. Sensorineural hearing loss in children. Lancet. 2005; Mar. 365(9462):879–90.

3. Kim NK, Kim AR, Park KT, Kim SY, Kim MY, Nam JY, et al. Whole-exome sequencing reveals diverse modes of inheritance in sporadic mild to moderate sensorineural hearing loss in a pediatric population. Genet Med. 2015; Nov. 17(11):901–11.

4. Kim BJ, Oh DY, Han JH, Oh J, Kim MY, Park HR, et al. Significant Mendelian genetic contribution to pediatric mild-to-moderate hearing loss and its comprehensive diagnostic approach. Genet Med. 2020; Jun. 22(6):1119–28.

5. Yu Y, Yang Y, Lu J, Jin Y, Yang Y, Hong E, et al. Two compound heterozygous were identified in SLC26A4 gene in two Chinese families with enlarged vestibular aqueduct. Clin Exp Otorhinolaryngol. 2019; Feb. 12(1):50–7.

6. Van Camp G, Smith RJ. Hereditary hearing loss homepage [Internet]. 2020. [cited 2020 Oct 19]. Available from: https://hereditaryhearingloss.org.

7. Choi SY, Kim YE, Ahn DB, Kim TH, Choi JH, Lee HR, et al. Construction of a DNA chip for screening of genetic hearing loss. Clin Exp Otorhinolaryngol. 2009; Mar. 2(1):44–7.

8. Han KH, Kim AR, Kim MY, Ahn S, Oh SH, Song JH, et al. Establishment of a flexible real-time polymerase chain reaction-based platform for detecting prevalent deafness mutations associated with variable degree of sensorineural hearing loss in Koreans. PLoS One. 2016; Sep. 11(9):e0161756.

9. Shearer AE, DeLuca AP, Hildebrand MS, Taylor KR, Gurrola J 2nd, Scherer S, et al. Comprehensive genetic testing for hereditary hearing loss using massively parallel sequencing. Proc Natl Acad Sci USA. 2010; Dec. 107(49):21104–9.

10. Tang W, Qian D, Ahmad S, Mattox D, Todd NW, Han H, et al. A low-cost exon capture method suitable for large-scale screening of genetic deafness by the massively-parallel sequencing approach. Genet Test Mol Biomarkers. 2012; Jun. 16(6):536–42.

11. Rehman AU, Morell RJ, Belyantseva IA, Khan SY, Boger ET, Shahzad M, et al. Targeted capture and next-generation sequencing identifies C9orf75, encoding taperin, as the mutated gene in nonsyndromic deafness DFNB79. Am J Hum Genet. 2010; Mar. 86(3):378–88.

12. Nishio SY, Usami SI. Outcomes of cochlear implantation for the patients with specific genetic etiologies: a systematic literature review. Acta Otolaryngol. 2017; Jul. 137(7):730–42.

13. Wu CC, Lin YH, Liu TC, Lin KN, Yang WS, Hsu CJ, et al. Identifying children with poor cochlear implantation outcomes using massively parallel sequencing. Medicine (Baltimore). 2015; Jul. 94(27):e1073.

14. Han KH, Oh DY, Lee S, Lee C, Han JH, Kim MY, et al. ATP1A3 mutations can cause progressive auditory neuropathy: a new gene of auditory synaptopathy. Sci Rep. 2017; Nov. 7(1):16504.

15. Kim BJ, Jang JH, Han JH, Park HR, Oh DY, Lee S, et al. Mutational and phenotypic spectrum of OTOF-related auditory neuropathy in Koreans: eliciting reciprocal interaction between bench and clinics. J Transl Med. 2018; Nov. 16(1):330.

16. Nakanishi H, Kawashima Y, Kurima K, Chae JJ, Ross AM, Pinto-Patarroyo G, et al. NLRP3 mutation and cochlear autoinflammation cause syndromic and nonsyndromic hearing loss DFNA34 responsive to anakinra therapy. Proc Natl Acad Sci U S A. 2017; Sep. 114(37):E7766–75.

17. Kim BJ, Kim YH, Lee S, Han S, Lee SY, Seong J, et al. Otological aspects of NLRP3-related autoinflammatory disorder focusing on the responsiveness to anakinra. Rheumatology (Oxford). 2020; Oct. 6. [Epub]. https://doi.org/10.1093/rheumatology/keaa511.

18. Nist-Lund CA, Pan B, Patterson A, Asai Y, Chen T, Zhou W, et al. Improved TMC1 gene therapy restores hearing and balance in mice with genetic inner ear disorders. Nat Commun. 2019; 10(1):236.